scorecardresearch
Add as a preferred source on Google
Sunday, February 15, 2026
TopicNovo Nordisk

Topic: Novo Nordisk

In battle for Indian anti-obesity market, Eli Lilly’s pre-filled pen on one side, Novo Nordisk’s on other

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.

Eli Lilly announces trial results for world’s 2nd weekly insulin, aims for launch by year-end

New Delhi: There is excitement and hope in the insulin market the world over after U.S. based pharma giant Eli Lilly & Company on...

Ozempic on steroids? Successor that could cut down weight in half the time coming soon

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its effectiveness in obesity management come out in 3 months.

On Camera

How Nehru defended restrictions on freedom of speech and the press

On 29 May 1951, Jawaharlal Nehru defended adding 'reasonable restrictions' to Article 19, arguing that free speech must be balanced with national security and unity.

Andhra proposes Rs 100-cr wealth fund, eyes Norway-style sovereign fund model to drive growth

Andhra Pradesh Finance Minister Payyavula Keshav presented a Rs 3.32 lakh crore budget for 2026–27 in the assembly Saturday.

Top US military commander applauds ‘India’s tactical execution’ during Op Sindoor; adds ‘there’s lessons too’

On bilateral ties, Admiral Paparo said India-US ties have an exponential effect on deterrence, because it demonstrates a unity of purpose among us to maintain the peace.

The new Great Game—Trump’s playing for time, China for leverage & India for wiggle room

This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they’d seen marginal interest. The starkest example is India & Europe.